GL1X · GenesisL1 explorer

MolNFT v1 · #117700 · protein

As (III) S-adenosylmethyltransferase cysteine mutant C72A bound phenylarsine oxide (PHAS(III) in the arsenic binding site

5EG5 · Arsenic methyltransferase: “As (III) S-adenosylmethyltransferase cysteine mutant C72A bound phenylarsine oxide (PHAS(III) in the arsenic…”. X-ray diffraction, 2 ligands (PA0, CA), 3 pockets (best druggability 0.54). MolNFT v1…

PDB
5EG5
Type
protein
Length
322 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Arsenic methyltransferase
UniProt
C0JV69
Ligands
PA0, CA
Pockets
3 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AArsenic methyltransferaseprotein32234% helix, 24% strandC0JV69

Ligands and binding sites

  • PA0 · Phenylarsine oxide · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11650.540.8026CA
2880.460.8119empty
31010.360.7427empty

Compared structures

  • 5EG5 · As (III) S-adenosylmethyltransferase cysteine mutant C72A bound Phenylarsine oxide… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.